Clinical Trial Update: Vortioxetine for Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from the University of Zurich investigates vortioxetine for newly diagnosed glioblastoma and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: University of Zurich | Conditions: Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING